RTsafe’s Founder and Chief Scientific Officer, Dr. Evangelos Pappas, will also participate in a panel discussion on Personalized Cancer Care which will take place at 2:30pm on Tue, November 26th.

I. Genitsarios Ltd. will be exclusive distributor of PseudoPatientâ„¢ products and services in Cyprus.

RTsafe today announced that its Personalized PseudoPatientâ„¢ product has received a 2019 R&D 100 Award from R&D World Magazine as one of the 100 most technologically significant products of the past year.